This entry was posted on Monday, March 31st, 2008 at 10:19 pm and is filed under Japan. You can follow any responses to this entry through the RSS 2.0 feed. Responses are currently closed, but you can trackback from your own site.
Cell Genesys, Japan’s Takeda to develop prostate-cancer therapy (Reuters via Yahoo! Malaysia News)
March 31 - Biotechnology company Cell Genesys Inc and Japan’s Takeda Pharmaceutical Co Ltd said they will develop and market Cell Genesys’ prostate-cancer therapy that is currently in late-stage clinical development.